| 21.70 Delayed Data As of Jul 22 |  -0.44 / -1.99%Today’s Change | 11.31 Today|||52-Week Range 33.13 | +65.40% Year-to-Date |
| Insmed Announces Closing of Public Offering of Common Stock Jun 26 / PR NewswirePRN - Paid Partner Content |
| Previous close | 22.14 |
| Today’s open | 22.14 |
| Day’s range | 21.63 - 22.23 |
| Volume | 1,006,683 |
| Average volume (3 months) | 929,622 |
| Market cap | $2.0B |
| Earnings growth (last year) | -45.93% |
| Earnings growth (this year) | +15.80% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 102.57 |
| Price/Book | 8.26 |
| Today’s change | Today’s % change | |
|---|---|---|
| ZGNXZogenix Inc | +0.14 | +0.29% |
| AKCAAkcea Therapeutics I... | +0.43 | +1.95% |
| PTLAPortola Pharmaceutic... | +0.07 | +0.26% |
| APLSApellis Pharmaceutic... | +1.97 | +7.25% |
| Next reporting date | August 1, 2019 |
| EPS forecast (this quarter) | -$0.87 |
| Annual revenue (last year) | $9.8M |
| Annual profit (last year) | -$324.3M |
| Net profit margin | -3,297.17% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Will Lewis |
Chief Technology Officer Walter R. Perkins |
Corporate headquarters Bridgewater, New Jersey |
